Phase I Study of U3-1287, a Fully Human Anti-HER3...

Clinical Cancer Research 2013 / 06 Vol. 19; Iss. 11

Phase I Study of U3-1287, a Fully Human Anti-HER3 Monoclonal Antibody, in Patients with Advanced Solid Tumors

LoRusso, P., Janne, P. A., Oliveira, M., Rizvi, N., Malburg, L., Keedy, V., Yee, L., Copigneaux, C., Hettmann, T., Wu, C.-Y., Ang, A., Halim, A.-B., Beckman, R. A., Beaupre, D., Berlin, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-12-3051
Date:
June, 2013
File:
PDF, 463 KB
english, 2013
Conversion to is in progress
Conversion to is failed